Symbol
SNDX on Nasdaq
Investment type
Equity / COMMON STOCK
Latest Disclosed Shares Owned
5,581,828 shares
Security Ownership %
6.5%
Shares, Excluding Options vs Price
Value, Excluding Options

THE GOLDMAN SACHS GROUP, INC. ownership in Syndax Pharmaceuticals Inc COMMON STOCK (SNDX)

13 Aug 2025 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,581,828 shares of Syndax Pharmaceuticals Inc COMMON STOCK (SNDX). This represents 6.5% ownership of the company. In their previous filing dated 09 May 2025, GOLDMAN SACHS GROUP INC had reported owning 4,510,669 shares, indicating an increase of +24%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.